Holmen Bob
Transaction: 06/10/2026
BUY
Change
+12,500
Price
$11.41
Filing
06/12/2026
Type
BUY
Sensei Biotherapeutics, Inc.
SNSE • Biotechnology
$13.85
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$17.94M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.08Healthy liquidity · 5.06Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 15, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$13.85
Change0.00%
Shares Out1.30M
Market Cap$17.94M
Enterprise Value$-183.82M
52W Range6.33 - 36.76
Beta-0.23
P/E-0.10
P/S-3.70
P/B0.09
P/FCF-0.74
EV/Sales37.89
Price$13.85
Change0.00%
Shares Out1.30M
Market Cap$17.94M
Enterprise Value$-183.82M
52W Range6.33 - 36.76
Beta-0.23
P/E-0.10
P/S-3.70
P/B0.09
P/FCF-0.74
EV/Sales37.89
EV/EBITDA1.00
EV/FCF7.62
FCF Yield-134.44%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.08
Current Ratio5.06
Quick Ratio5.06
Target$50.00
Target Upside261.01%
Target Median$50.00
Target Range50.00 - 50.00
Volume219.47K
Avg Volume52.12K
EPS Surprise-130.83
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.08Healthy liquidity · 5.06Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-09-05
83/100
Bullish
Bullish
4
Hold
2
Bearish
0
Price Target
2026-07-02
Low
$50.00
Mean
$50.00
Median
$50.00
High
$50.00
Insider Transactions
Recent executive and insider activity
Donenberg Phillip B.
Transaction: 06/10/2026
BUY
Change
+12,500
Price
$11.41
Filing
06/12/2026
Type
BUY
Gerry Christopher
Transaction: 06/10/2026
BUY
Change
+220,000
Price
$29.89
Filing
06/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Holmen Bob | BUY | +12,500 | $11.41 | 06/10/2026 | 06/12/2026 |
| Donenberg Phillip B. | BUY | +12,500 | $11.41 | 06/10/2026 | 06/12/2026 |
| Gerry Christopher | BUY | +220,000 | $29.89 | 06/10/2026 | 06/12/2026 |
| Peyer James | SELL | -476 | $21.14 | 06/01/2026 | 06/01/2026 |
| Cambrian BioPharma Inc | SELL | -476 | $21.14 | 06/01/2026 | 06/01/2026 |
| MILLENNIUM MANAGEMENT LLC | SELL | -1,108 | $33.38 | 04/07/2026 | 05/15/2026 |
| MILLENNIUM MANAGEMENT LLC | SELL | -45 | $31.96 | 04/06/2026 | 05/15/2026 |
| MILLENNIUM MANAGEMENT LLC | SELL | -374 | $33.35 | 04/02/2026 | 05/15/2026 |
| MILLENNIUM MANAGEMENT LLC | SELL | -46 | $34.75 | 04/01/2026 | 05/15/2026 |
| MILLENNIUM MANAGEMENT LLC | BUY | +186 | $30.48 | 03/31/2026 | 05/15/2026 |
| MILLENNIUM MANAGEMENT LLC | SELL | -370 | $27.68 | 03/30/2026 | 05/15/2026 |
| MILLENNIUM MANAGEMENT LLC | SELL | -36 | $27.37 | 03/27/2026 | 05/15/2026 |
| MILLENNIUM MANAGEMENT LLC | OTHER | 0 | Not reported | 03/26/2026 | 05/15/2026 |
| Donenberg Phillip B. | BUY | +23,100 | $29.89 | 04/10/2026 | 04/14/2026 |
| Craver Josiah | BUY | +80,000 | $29.89 | 04/10/2026 | 04/14/2026 |
| Parikh Anand Kiran | BUY | +1,239,305 | $27.22 | 02/19/2026 | 02/19/2026 |
| Parikh Anand Kiran | OTHER | 0 | Not reported | 02/17/2026 | 02/19/2026 |
| Parikh Anand Kiran | BUY | +56,673 | $1.16 | 02/17/2026 | 02/19/2026 |
| Parikh Anand Kiran | BUY | +809,822 | Not reported | 02/17/2026 | 02/19/2026 |
| Donenberg Phillip B. | OTHER | 0 | Not reported | 02/13/2026 | 02/17/2026 |